Generic Name and Formulations:
Benzoyl peroxide 2.5%, 5%, 10%; aqueous-base gel.
Galderma Laboratories, Inc.
- Sphenopalatine Ganglion Blockade Improves Connectivity in Medication Overuse Headache
- Mixing Sedative-Hypnotics, Prescription Opioids Associated With Suicidal Ideation in Serious Mental Illness
- Chronic Migraine Associated With Age-Related Changes in Cortical Thickness
- Narcotic Analgesic Formulations
- Migraine and Headache Treatments
- Medication-Alcohol Pharmacologic Interactions
Indications for BENZAC-W:
Initially apply to cleansed area once daily, increase to 2–3 times daily as tolerated.
Avoid eyes, mouth, and mucous membranes. Pregnancy (Cat.C). Nursing mothers.
Antibacterial + keratolytic.
PABA sunscreens may transiently discolor skin.
Excessive drying, allergic dermatitis, may bleach fabrics or hair.
Gel—60g; Wash 5%—4oz, 8oz; 10%—8oz
Clinical Pain Advisor Articles
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis